196 related articles for article (PubMed ID: 17652170)
1. An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.
Huyton T; Zhang JG; Luo CS; Lou MZ; Hilton DJ; Nicola NA; Garrett TP
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12737-42. PubMed ID: 17652170
[TBL] [Abstract][Full Text] [Related]
2. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex.
Skiniotis G; Lupardus PJ; Martick M; Walz T; Garcia KC
Mol Cell; 2008 Sep; 31(5):737-48. PubMed ID: 18775332
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
Metz S; Naeth G; Heinrich PC; Müller-Newen G
J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
5. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor.
Hammacher A; Richardson RT; Layton JE; Smith DK; Angus LJ; Hilton DJ; Nicola NA; Wijdenes J; Simpson RJ
J Biol Chem; 1998 Aug; 273(35):22701-7. PubMed ID: 9712900
[TBL] [Abstract][Full Text] [Related]
6. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
7. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
8. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor (LIF).
Nicola NA; Babon JJ
Cytokine Growth Factor Rev; 2015 Oct; 26(5):533-44. PubMed ID: 26187859
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor ligand-receptor signaling is important for uterine receptivity and implantation in golden hamsters (Mesocricetus auratus).
Ding T; Song H; Wang X; Khatua A; Paria BC
Reproduction; 2008 Jan; 135(1):41-53. PubMed ID: 18159082
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation facilitates LIF entry into brain: role of TNF.
Pan W; Yu C; Hsuchou H; Zhang Y; Kastin AJ
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1436-42. PubMed ID: 18385284
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of a specific receptor for mouse oncostatin M.
Lindberg RA; Juan TS; Welcher AA; Sun Y; Cupples R; Guthrie B; Fletcher FA
Mol Cell Biol; 1998 Jun; 18(6):3357-67. PubMed ID: 9584176
[TBL] [Abstract][Full Text] [Related]
14. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
Smith DK; Treutlein HR
Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
[TBL] [Abstract][Full Text] [Related]
15. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
16. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
He SX; Song G; Shi JP; Guo YQ; Guo ZY
Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
[TBL] [Abstract][Full Text] [Related]
17. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
Song H; Lim H
Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
[TBL] [Abstract][Full Text] [Related]
18. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
[TBL] [Abstract][Full Text] [Related]
19. Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex.
Port MD; Gibson RM; Nathanson NM
J Neurochem; 2007 May; 101(3):782-93. PubMed ID: 17448148
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of leukemia inhibitory factor receptor antagonists as candidate therapeutics for inflammatory arthritis.
Jazayeri JA; De Weerd N; Raye W; Kivivuori S; Zabihi E; Carroll GJ
J Interferon Cytokine Res; 2007 Apr; 27(4):281-9. PubMed ID: 17477816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
